European Archives - Page 566 of 1108 - European Medical Journal

EMJ 6.2 Feature Image

Pioneering Best Practices in Atopic Dermatitis: Results from the Quality of Care Initiative

Pioneering global best practices in atopic dermatitis (AD) and implementing them in the clinic are important steps towards optimising patient care…

EMJ 6.2 Feature Image

EMJ 6.2 2021

The second flagship journal of 2021 comprises a selection of articles highlighting key advances across a range of therapeutic disciplines including haematology, rheumatology, respiratory medicine, and more. Themes covered in this issue appeal to a broad range of healthcare professionals and include COVID-19, acute myeloid leukaemia, and Ehlers-Danlos Syndrome, among others.

Late-Breaking Abstracts: Health Status Benefits of Mavacamten in Obstructive Hypertrophic Cardiomyopathy and the Modifying Effect of Ejection Fraction on the Therapeutic Benefit of Omecamtiv Mecarbil in Heart Failure

Two late-breaking abstracts at the American College of Cardiology’s virtual meeting ACC.21 delved further into the data of two pivotal trials

EMJ 6.2 Feature Image

Understanding the Impact of Non-Dystrophic Myotonia on Patients and Caregivers: Results from a Burden of Disease Healthcare Survey

Non-dystrophic myotonias (NDM) manifest as delayed muscle relaxation (myotonia) leading to muscle stiffness that may diminish or worsen…

Prevalence of Scoliosis in Hypermobile Ehlers-Danlos Syndrome

The main purpose of this study was to evaluate the prevalence, form, and severity of scoliosis in a population of adults meeting the 2017 criteria for hypermobile Ehlers-Danlos syndrome (hEDS).

Pre-transplant Determinants of Outcome in Patients with Myeloma

Multiple myeloma is a malignant neoplasm arising from clonal proliferation of plasma cells in the bone marrow…

New Therapeutic Approaches for Acute Myeloid Leukaemia

Acute myeloid leukaemia (AML) is a life-threatening, multifactorial haematological neoplasm characterised by the accumulation of transformed immature myeloid progenitors…

Prevalence of Thromboembolic Complications in COVID-19 Infection: A Systematic Review and Meta-Analysis

This study aims to evaluate the prevalence of thromboembolic complications in patients with COVID-19 from March until May 2020.

3D Bone Marrow Model Helps Predict Treatment Response

3D Bone Marrow Model Helps Predict Treatment Response

Predicting individual patient response, as well as progressing understanding of new therapies in development, may be improved by the use of a newly developed 3D bone marrow model.

First Effective Treatment of COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia

First Effective Treatment of COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia

Balancing risk of adverse reactions against the protection of effective vaccination is a hotly debated topic in the current phase of the global response to the COVID-19 pandemic. Rare blood clot reactions have been of particular concern, and a recently published case report shares the first successful treatment of a vaccine-induced thrombosis reaction.